• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身缺失可保护小鼠免受年龄诱导的体重增加、胰岛素抵抗和代谢功能障碍。

Whole Body Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction.

作者信息

Ghoshal Sarbani, Mukherjee Sandip, Chakraborty Molee, Msengi Eliwaza Naomi, Haubner Jake, Chakraborty Anutosh

机构信息

Department of Metabolism and Aging, The Scripps Research Institute, Jupiter, FL 33458, USA.

Department of Biological Sciences and Geology, QCC-City University of New York, New York, NY 11364, USA.

出版信息

Int J Mol Sci. 2022 Feb 12;23(4):2059. doi: 10.3390/ijms23042059.

DOI:10.3390/ijms23042059
PMID:35216174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8878859/
Abstract

(1) Background: We previously demonstrated that disruption of IP6K1 improves metabolism, protecting mice from high-fat diet-induced obesity, insulin resistance, and non-alcoholic fatty liver disease and steatohepatitis. Age-induced metabolic dysfunction is a major risk factor for metabolic diseases. The involvement of IP6K1 in this process is unknown. (2) Methods: Here, we compared body and fat mass, insulin sensitivity, energy expenditure and serum-, adipose tissue- and liver-metabolic parameters of chow-fed, aged, wild type () and whole body knockout () mice. (3) Results: IP6K1 was upregulated in the adipose tissue and liver of mice compared to young mice. Moreover, deletion blocked age-induced increase in body- and fat-weight and insulin resistance in mice. mice oxidized carbohydrates more efficiently. The knockouts displayed reduced levels of serum insulin, triglycerides, and non-esterified fatty acids. deletion partly protected age-induced decline of the thermogenic uncoupling protein UCP1 in inguinal white adipose tissue. Targets inhibited by IP6K1 activity such as the insulin sensitivity- and energy expenditure-inducing protein kinases, protein kinase B (PKB/Akt) and AMP-activated protein kinase (AMPK), were activated in the adipose tissue and liver of mice. (4) Conclusions: deletion maintains healthy metabolism in aging and thus, targeting this kinase may delay the development of age-induced metabolic dysfunction.

摘要

(1) 背景:我们之前证明,IP6K1的缺失可改善新陈代谢,保护小鼠免受高脂饮食诱导的肥胖、胰岛素抵抗、非酒精性脂肪性肝病和脂肪性肝炎的影响。年龄诱导的代谢功能障碍是代谢性疾病的主要危险因素。IP6K1在此过程中的作用尚不清楚。(2) 方法:在此,我们比较了正常饮食喂养的老年野生型()和全身敲除()小鼠的体重、脂肪量、胰岛素敏感性、能量消耗以及血清、脂肪组织和肝脏的代谢参数。(3) 结果:与年轻小鼠相比,老年小鼠脂肪组织和肝脏中IP6K1上调。此外,敲除可阻止小鼠年龄诱导的体重和脂肪量增加以及胰岛素抵抗。小鼠能更有效地氧化碳水化合物。敲除小鼠血清胰岛素、甘油三酯和非酯化脂肪酸水平降低。敲除部分保护了腹股沟白色脂肪组织中年龄诱导的产热解偶联蛋白UCP1的下降。IP6K1活性抑制的靶点,如诱导胰岛素敏感性和能量消耗的蛋白激酶蛋白激酶B(PKB/Akt)和AMP激活的蛋白激酶(AMPK),在敲除小鼠的脂肪组织和肝脏中被激活。(4) 结论:敲除可维持衰老过程中的健康代谢,因此,靶向这种激酶可能会延缓年龄诱导的代谢功能障碍的发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/df8a73d336c7/ijms-23-02059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/7b4c7b98bda8/ijms-23-02059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/b5367f2932f7/ijms-23-02059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/b67ddc470003/ijms-23-02059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/df8a73d336c7/ijms-23-02059-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/7b4c7b98bda8/ijms-23-02059-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/b5367f2932f7/ijms-23-02059-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/b67ddc470003/ijms-23-02059-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/af15/8878859/df8a73d336c7/ijms-23-02059-g004.jpg

相似文献

1
Whole Body Deletion Protects Mice from Age-Induced Weight Gain, Insulin Resistance and Metabolic Dysfunction.全身缺失可保护小鼠免受年龄诱导的体重增加、胰岛素抵抗和代谢功能障碍。
Int J Mol Sci. 2022 Feb 12;23(4):2059. doi: 10.3390/ijms23042059.
2
Adipocyte-specific deletion of Ip6k1 reduces diet-induced obesity by enhancing AMPK-mediated thermogenesis.脂肪细胞特异性缺失Ip6k1通过增强AMPK介导的产热作用减轻饮食诱导的肥胖。
J Clin Invest. 2016 Nov 1;126(11):4273-4288. doi: 10.1172/JCI85510. Epub 2016 Oct 4.
3
Global IP6K1 deletion enhances temperature modulated energy expenditure which reduces carbohydrate and fat induced weight gain.全球 IP6K1 缺失增强了温度调节的能量消耗,从而减少了碳水化合物和脂肪引起的体重增加。
Mol Metab. 2016 Nov 28;6(1):73-85. doi: 10.1016/j.molmet.2016.11.010. eCollection 2017 Jan.
4
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.IP6K1 的多效作用介导肝代谢功能障碍,促进非酒精性脂肪性肝病和脂肪性肝炎。
Mol Metab. 2021 Dec;54:101364. doi: 10.1016/j.molmet.2021.101364. Epub 2021 Oct 28.
5
TNP [N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine] ameliorates diet induced obesity and insulin resistance via inhibition of the IP6K1 pathway.TNP [N2-(间三氟苄基),N6-(对硝基苄基)嘌呤] 通过抑制IP6K1途径改善饮食诱导的肥胖和胰岛素抵抗。
Mol Metab. 2016 Aug 21;5(10):903-917. doi: 10.1016/j.molmet.2016.08.008. eCollection 2016 Oct.
6
Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.靶向代谢疾病中的肌醇焦磷酸生物合成酶。
Molecules. 2020 Mar 19;25(6):1403. doi: 10.3390/molecules25061403.
7
Inositol hexakisphosphate kinase-1 interacts with perilipin1 to modulate lipolysis.肌醇六磷酸激酶-1与脂滴包被蛋白1相互作用以调节脂肪分解。
Int J Biochem Cell Biol. 2016 Sep;78:149-155. doi: 10.1016/j.biocel.2016.06.018. Epub 2016 Jun 29.
8
Inositol pyrophosphates inhibit Akt signaling, thereby regulating insulin sensitivity and weight gain.肌醇焦磷酸盐抑制 Akt 信号通路,从而调节胰岛素敏感性和体重增加。
Cell. 2010 Dec 10;143(6):897-910. doi: 10.1016/j.cell.2010.11.032.
9
PI3Ka-Akt1-mediated Prdm4 induction in adipose tissue increases energy expenditure, inhibits weight gain, and improves insulin resistance in diet-induced obese mice.PI3Ka-Akt1 介导的脂肪组织中 Prdm4 的诱导增加能量消耗,抑制饮食诱导肥胖小鼠体重增加,并改善胰岛素抵抗。
Cell Death Dis. 2018 Aug 29;9(9):876. doi: 10.1038/s41419-018-0904-3.
10
Fish Oil Protects Wild Type and Uncoupling Protein 1-Deficient Mice from Obesity and Glucose Intolerance by Increasing Energy Expenditure.鱼油通过增加能量消耗来保护野生型和解偶联蛋白 1 缺陷型小鼠免于肥胖和葡萄糖不耐受。
Mol Nutr Food Res. 2019 Apr;63(7):e1800813. doi: 10.1002/mnfr.201800813. Epub 2019 Jan 17.

引用本文的文献

1
Adipose tissue aging as a risk factor for metabolic organ abnormalities: mechanistic insights and the role of exercise interventions.脂肪组织衰老作为代谢器官异常的一个风险因素:机制见解及运动干预的作用
Lipids Health Dis. 2025 Sep 2;24(1):274. doi: 10.1186/s12944-025-02695-3.
2
Insights into the roles of inositol hexakisphosphate kinase 1 (IP6K1) in mammalian cellular processes.对肌醇六磷酸激酶1(IP6K1)在哺乳动物细胞过程中作用的见解。
J Biol Chem. 2024 Apr;300(4):107116. doi: 10.1016/j.jbc.2024.107116. Epub 2024 Feb 24.
3
The IP6K Inhibitor LI-2242 Ameliorates Diet-Induced Obesity, Hyperglycemia, and Hepatic Steatosis in Mice by Improving Cell Metabolism and Insulin Signaling.

本文引用的文献

1
Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.IP6K1 的多效作用介导肝代谢功能障碍,促进非酒精性脂肪性肝病和脂肪性肝炎。
Mol Metab. 2021 Dec;54:101364. doi: 10.1016/j.molmet.2021.101364. Epub 2021 Oct 28.
2
5-IP is a GPCR messenger mediating neural control of synaptotagmin-dependent insulin exocytosis and glucose homeostasis.5-IP是一种G蛋白偶联受体信使分子,介导对依赖突触结合蛋白的胰岛素胞吐作用和葡萄糖稳态的神经控制。
Nat Metab. 2021 Oct;3(10):1400-1414. doi: 10.1038/s42255-021-00468-7. Epub 2021 Oct 18.
3
The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals.
IP6K 抑制剂 LI-2242 通过改善细胞代谢和胰岛素信号通路改善饮食诱导的肥胖、高血糖和肝脂肪变性。
Biomolecules. 2023 May 20;13(5):868. doi: 10.3390/biom13050868.
4
The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.生热脂肪的不断演变的观点及其在癌症和代谢性疾病中的意义。
Signal Transduct Target Ther. 2022 Sep 16;7(1):324. doi: 10.1038/s41392-022-01178-6.
肌醇六磷酸激酶的酶活性控制哺乳动物循环中的磷酸盐。
Nat Commun. 2021 Aug 11;12(1):4847. doi: 10.1038/s41467-021-24934-8.
4
Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.通过高通量筛选鉴定人肌醇六磷酸激酶的小分子抑制剂
ACS Pharmacol Transl Sci. 2021 Mar 3;4(2):780-789. doi: 10.1021/acsptsci.0c00218. eCollection 2021 Apr 9.
5
Energy Metabolism and Aging.能量代谢与衰老
World J Mens Health. 2021 Apr;39(2):222-232. doi: 10.5534/wjmh.200112. Epub 2020 Aug 28.
6
The metabolic basis of nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的代谢基础
Endocrinol Diabetes Metab. 2020 Feb 24;3(4):e00112. doi: 10.1002/edm2.112. eCollection 2020 Oct.
7
Thermoneutral conditions correct the obese phenotype in female, but not male, Kiss1r knockout mice.在热中性条件下,肥胖表型在雌性 Kiss1r 基因敲除小鼠中得到纠正,但在雄性小鼠中则没有。
J Therm Biol. 2020 May;90:102592. doi: 10.1016/j.jtherbio.2020.102592. Epub 2020 Apr 20.
8
Inositol Pyrophosphates: Energetic, Omnipresent and Versatile Signalling Molecules.肌醇焦磷酸:能量丰富、无处不在且功能多样的信号分子。
J Indian Inst Sci. 2017;97(1):23-40. doi: 10.1007/s41745-016-0011-3. Epub 2017 Feb 28.
9
Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.靶向代谢疾病中的肌醇焦磷酸生物合成酶。
Molecules. 2020 Mar 19;25(6):1403. doi: 10.3390/molecules25061403.
10
Metabolic adaptation and maladaptation in adipose tissue.脂肪组织的代谢适应和失调。
Nat Metab. 2019 Feb;1(2):189-200. doi: 10.1038/s42255-018-0021-8. Epub 2019 Jan 21.